Large global clinical trials are a necessary step in clinical development for most pharmaceutical therapies but these studies often encounter challenges that have a substantial impact on timeline and budget; two critical elements for sponsors. The most common issues relate to the timeline for enrollment and the impact of suboptimal patient retention